$NWBO
NORTHWEST BIOTHERAPEUTICS INC

2019 Q1 Form 10-Q Financial Statement

#000114420419025347 Filed on May 10, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q4 2018 Q1
Revenue $339.0K $412.0K $132.0K
YoY Change 156.82% 1273.33% 94.12%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.101M $27.02M $4.220M
YoY Change 20.88% 472.35% -39.19%
% of Gross Profit
Research & Development $3.004M $18.15M $4.733M
YoY Change -36.53% 48964.86% -6.0%
% of Gross Profit
Depreciation & Amortization $2.000K $228.0K $365.0K
YoY Change -99.45% -24.0% 551.79%
% of Gross Profit
Operating Expenses $3.004M $45.17M $4.733M
YoY Change -36.53% 121978.38% -6.0%
Operating Profit -$7.766M -$8.816M
YoY Change -11.91%
Interest Expense $756.0K $5.602M $3.324M
YoY Change -77.26% -180.37% 178.39%
% of Operating Profit
Other Income/Expense, Net -$13.18M $0.00 -$12.73M
YoY Change 3.54%
Pretax Income -$20.95M -$35.79M -$21.55M
YoY Change -2.8% 32.57% 70.76%
Income Tax
% Of Pretax Income
Net Earnings -$20.95M -$35.79M -$21.55M
YoY Change -2.78% 32.57% 70.72%
Net Earnings / Revenue -6178.76% -8687.86% -16321.97%
Basic Earnings Per Share
Diluted Earnings Per Share -$39.59K -$81.35K -$60.51K
COMMON SHARES
Basic Shares Outstanding 513.4M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q4 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $16.29M $22.22M $200.0K
YoY Change 8044.0% 18420.0% -89.13%
Cash & Equivalents $1.970M $22.22M $198.0K
Short-Term Investments
Other Short-Term Assets $2.293M $1.574M $930.0K
YoY Change 146.56% 22.02% -29.55%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $18.58M $23.80M $1.130M
YoY Change 1544.34% 1597.43% -64.24%
LONG-TERM ASSETS
Property, Plant & Equipment $277.0K $108.0K $48.57M
YoY Change -99.43% -99.77% 7.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $748.0K $761.0K $80.00K
YoY Change 835.0% 4376.47% -38.46%
Total Long-Term Assets $5.889M $869.0K $48.65M
YoY Change -87.9% -98.17% 7.74%
TOTAL ASSETS
Total Short-Term Assets $18.58M $23.80M $1.130M
Total Long-Term Assets $5.889M $869.0K $48.65M
Total Assets $24.47M $24.67M $49.78M
YoY Change -50.84% -49.56% 3.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.05M $20.09M $20.28M
YoY Change -11.02% 9.21% 57.7%
Accrued Expenses $270.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $14.05M $14.81M $20.38M
YoY Change -31.08% -24.43% -19.35%
Total Short-Term Liabilities $74.22M $69.84M $103.7M
YoY Change -28.42% -20.35% 26.59%
LONG-TERM LIABILITIES
Long-Term Debt $4.001M $1.986M $9.120M
YoY Change -56.13% -76.69% 199.02%
Other Long-Term Liabilities $4.749M
YoY Change
Total Long-Term Liabilities $8.750M $1.986M $9.116M
YoY Change -4.01% -76.68% 199.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $74.22M $69.84M $103.7M
Total Long-Term Liabilities $8.750M $1.986M $9.116M
Total Liabilities $82.97M $71.83M $112.8M
YoY Change -26.45% -25.34% 32.78%
SHAREHOLDERS EQUITY
Retained Earnings -$840.6M -$824.4M
YoY Change 4.54%
Common Stock $781.0M $776.3M $730.9M
YoY Change 6.85% 7.53% 5.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$58.50M -$48.13M -$80.82M
YoY Change
Total Liabilities & Shareholders Equity $24.47M $24.67M $49.78M
YoY Change -50.84% -49.56% 3.03%

Cashflow Statement

Concept 2019 Q1 2018 Q4 2018 Q1
OPERATING ACTIVITIES
Net Income -$20.95M -$35.79M -$21.55M
YoY Change -2.78% 32.57% 70.72%
Depreciation, Depletion And Amortization $2.000K $228.0K $365.0K
YoY Change -99.45% -24.0% 551.79%
Cash From Operating Activities -$9.751M -$14.18M -$4.787M
YoY Change 103.7% -4.2% -61.03%
INVESTING ACTIVITIES
Capital Expenditures -$164.0K -$193.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $45.60M $0.00
YoY Change -100.0%
Cash From Investing Activities -$164.0K $45.40M $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.939M -10.82M 6.762M
YoY Change -41.75% -175.72% -15.98%
NET CHANGE
Cash From Operating Activities -9.751M -14.18M -4.787M
Cash From Investing Activities -164.0K 45.40M 0.000
Cash From Financing Activities 3.939M -10.82M 6.762M
Net Change In Cash -5.976M 20.40M 1.975M
YoY Change -402.58% -4100.59% -149.17%
FREE CASH FLOW
Cash From Operating Activities -$9.751M -$14.18M -$4.787M
Capital Expenditures -$164.0K -$193.0K
Free Cash Flow -$9.587M -$13.98M
YoY Change -5.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2019Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q1 dei Entity Registrant Name
EntityRegistrantName
NORTHWEST BIOTHERAPEUTICS INC
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001072379
CY2019Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2019Q1 dei Trading Symbol
TradingSymbol
NWBO
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
544469782
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16288000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22224000
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2293000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1574000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
18581000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
23798000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
277000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
108000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
748000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
761000
CY2019Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
5889000
CY2018Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
869000
CY2019Q1 us-gaap Assets
Assets
24470000
CY2018Q4 us-gaap Assets
Assets
24667000
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
537000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
523000
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24470000
CY2019Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15316000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15506000
CY2019Q1 nwbo Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
2729000
CY2018Q4 nwbo Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
4588000
CY2019Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
852000
CY2018Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1863000
CY2019Q1 nwbo Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
5400000
CY2018Q4 nwbo Convertible Notes Payable Related Parties Current
ConvertibleNotesPayableRelatedPartiesCurrent
5400000
CY2019Q1 us-gaap Notes Payable Current
NotesPayableCurrent
7729000
CY2018Q4 us-gaap Notes Payable Current
NotesPayableCurrent
7155000
CY2019Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
65000
CY2018Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
393000
CY2019Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
41717000
CY2018Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
29995000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
74216000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
69840000
CY2019Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
4001000
CY2018Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1986000
CY2019Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8750000
CY2018Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1986000
CY2019Q1 us-gaap Liabilities
Liabilities
82966000
CY2018Q4 us-gaap Liabilities
Liabilities
71826000
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
780478000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
775741000
CY2019Q1 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
10000
CY2018Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
10000
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1056000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-58496000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-47159000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-840557000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-824413000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24667000
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
339000
CY2018Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
132000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3004000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4733000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3562000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3005000
CY2019Q1 us-gaap Legal Fees
LegalFees
1539000
CY2018Q1 us-gaap Legal Fees
LegalFees
1210000
CY2019Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-12021000
CY2018Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-11451000
CY2019Q1 us-gaap Interest Expense
InterestExpense
756000
CY2018Q1 us-gaap Interest Expense
InterestExpense
3324000
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
385000
CY2018Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
1831000
CY2019Q1 nwbo Deemed Dividend On Convertible Preferred Stock
DeemedDividendOnConvertiblePreferredStock
0
CY2018Q1 nwbo Deemed Dividend On Convertible Preferred Stock
DeemedDividendOnConvertiblePreferredStock
10056000
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-788000
CY2018Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
215000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
537100000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
523200000
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
537100000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
523200000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000
CY2019Q1 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
147000
CY2019Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
41864000
CY2018Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
357000
CY2018Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
30352000
CY2019Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
18982000
CY2019Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1082000
CY2018Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
17435000
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
900000
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; text-indent: 1.13in; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In preparing condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions include valuing equity securities in share-based payment arrangements, estimating the fair value of financial instruments recorded as derivative liabilities, useful lives of depreciable assets and whether impairment charges may apply, and the fair value of environmental remediation liabilities.</div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1200000000
CY2019Q1 us-gaap Depreciation
Depreciation
2000
CY2018Q1 us-gaap Depreciation
Depreciation
365000
CY2019Q1 nwbo Fair Value Of Embedded Conversion Option
FairValueOfEmbeddedConversionOption
147000
CY2019Q1 us-gaap Long Term Debt
LongTermDebt
18047000
CY2018Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
995000
CY2018Q4 nwbo Fair Value Of Embedded Conversion Option
FairValueOfEmbeddedConversionOption
357000
CY2018Q4 us-gaap Long Term Debt
LongTermDebt
16797000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-67333000
CY2018Q1 nwbo Adjustments To Additional Paid In Capital Beneficial Conversion Feature Of Series B Convertible Preferred Stock
AdjustmentsToAdditionalPaidInCapitalBeneficialConversionFeatureOfSeriesBConvertiblePreferredStock
388000
CY2018Q1 nwbo Stock Issued During Period Value Conversion Of Convertible Preferred Stock
StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStock
11311000
CY2018Q1 nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
1611000
CY2018Q1 nwbo Adjustments To Additional Paid In Capitaldeemed Dividends Related To Accretion Of Redemption Value Of Series B Convertible Stock
AdjustmentsToAdditionalPaidInCapitaldeemedDividendsRelatedToAccretionOfRedemptionValueOfSeriesBConvertibleStock
388000
CY2018Q1 nwbo Adjustments To Additional Paid In Capitaldeemed Dividends Related To Conversion Of Preferred Convertible Stock Into Common Stock
AdjustmentsToAdditionalPaidInCapitaldeemedDividendsRelatedToConversionOfPreferredConvertibleStockIntoCommonStock
-9491000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
304000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-21545000
CY2018Q1 nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
1747000
CY2018Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1074000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-47159000
CY2019Q1 nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
688000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
553000
CY2019Q1 nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
509000
CY2019Q1 nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
3001000
CY2018Q1 nwbo Stock Issued During Period Value Conversion Of Convertible Preferred Stock One
StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStockOne
994000
CY2019Q1 us-gaap Interest Expense Other
InterestExpenseOther
1000
CY2018Q1 us-gaap Interest Expense Other
InterestExpenseOther
1000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-870000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-80823000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
56000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-58496000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-21545000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2000
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
365000
CY2019Q1 nwbo Amortization Of Debt Discount
AmortizationOfDebtDiscount
296000
CY2018Q1 nwbo Amortization Of Debt Discount
AmortizationOfDebtDiscount
2627000
CY2019Q1 nwbo Amortization Of Debt Premium
AmortizationOfDebtPremium
0
CY2018Q1 nwbo Amortization Of Debt Premium
AmortizationOfDebtPremium
151000
CY2019Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-12021000
CY2018Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-11451000
CY2019Q1 nwbo Stock Based Compensation Related To Warrants Modification
StockBasedCompensationRelatedToWarrantsModification
0
CY2018Q1 nwbo Stock Based Compensation Related To Warrants Modification
StockBasedCompensationRelatedToWarrantsModification
141000
CY2019Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
553000
CY2018Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
304000
CY2019Q1 us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
13686000
CY2018Q1 us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
14522000
CY2019Q1 nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
705000
CY2018Q1 nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-362000
CY2019Q1 nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
-9000
CY2018Q1 nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
62000
CY2019Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-65000
CY2018Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-628000
CY2019Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-1859000
CY2018Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
2564000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9751000
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
372153
CY2018Q4 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.29
CY2019Q1 nwbo Number Of Warrants Warrants Exercised For Cash
NumberOfWarrantsWarrantsExercisedForCash
2986
CY2019Q1 nwbo Weighted Average Exercise Price Exercised For Cash
WeightedAverageExercisePriceExercisedForCash
0.23
CY2019Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
369167
CY2019Q1 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.29
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
498842000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
508269000
CY2019Q1 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
64000
CY2018Q1 us-gaap Debt Instrument Increase Decrease Other Net
DebtInstrumentIncreaseDecreaseOtherNet
30000
CY2019Q1 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
138000
CY2018Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
138000
CY2019Q1 us-gaap Sale Leaseback Transaction Deferred Gain Net
SaleLeasebackTransactionDeferredGainNet
0
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
529133000
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
356162000
CY2018Q1 nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
1552000
CY2018Q1 nwbo Adjustments To Additional Paid In Capital Deemed Dividends On Conversion Of Series B Convertible Preferred Stock To Common Stock
AdjustmentsToAdditionalPaidInCapitalDeemedDividendsOnConversionOfSeriesBConvertiblePreferredStockToCommonStock
-177000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4787000
CY2019Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
164000
CY2018Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
0
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-164000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2019Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
688000
CY2018Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1611000
CY2019Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
4000000
CY2018Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
CY2019Q1 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
0
CY2018Q1 us-gaap Increase Decrease In Notes Payable Related Parties
IncreaseDecreaseInNotesPayableRelatedParties
30000
CY2019Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2018Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4400000
CY2019Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
420000
CY2018Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2200000
CY2019Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
329000
CY2018Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
250000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3939000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6762000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
40000
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1894000
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5936000
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
81000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22224000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
117000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16288000
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
198000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
553000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
270000
CY2019Q1 nwbo Class Of Warrants Or Right Number Issued
ClassOfWarrantsOrRightNumberIssued
800000
CY2019Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
1450000
CY2018Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
3314000
CY2019Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.30
CY2019Q1 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
2200000
CY2018Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
65000
CY2018Q4 us-gaap Sale Leaseback Transaction Deferred Gain Net
SaleLeasebackTransactionDeferredGainNet
4802000
CY2019Q1 nwbo Stock Issued During Period Value Conversion Of Convertible Preferred Stock
StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStock
0
CY2018Q1 nwbo Stock Issued During Period Value Conversion Of Convertible Preferred Stock
StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStock
11311000
CY2019Q1 nwbo Deemed Dividends On Conversion Of Series Convertible Preferred Stock To Common Stock
DeemedDividendsOnConversionOfSeriesConvertiblePreferredStockToCommonStock
0
CY2018Q1 nwbo Deemed Dividends On Conversion Of Series Convertible Preferred Stock To Common Stock
DeemedDividendsOnConversionOfSeriesConvertiblePreferredStockToCommonStock
9491000
CY2019Q1 nwbo Adjustments To Additional Paid In Capital Beneficial Conversion Feature Of Series B Convertible Preferred Stock
AdjustmentsToAdditionalPaidInCapitalBeneficialConversionFeatureOfSeriesBConvertiblePreferredStock
0
CY2018Q1 nwbo Adjustments To Additional Paid In Capital Beneficial Conversion Feature Of Series B Convertible Preferred Stock
AdjustmentsToAdditionalPaidInCapitalBeneficialConversionFeatureOfSeriesBConvertiblePreferredStock
388000
CY2019Q1 nwbo Adjustments To Additional Paid In Capitaldeemed Dividends Related To Accretion Of Redemption Value Of Series B Convertible Stock
AdjustmentsToAdditionalPaidInCapitaldeemedDividendsRelatedToAccretionOfRedemptionValueOfSeriesBConvertibleStock
0
CY2018Q1 nwbo Adjustments To Additional Paid In Capitaldeemed Dividends Related To Accretion Of Redemption Value Of Series B Convertible Stock
AdjustmentsToAdditionalPaidInCapitaldeemedDividendsRelatedToAccretionOfRedemptionValueOfSeriesBConvertibleStock
388000
CY2019Q1 nwbo Stock Issued During Period Value Conversion Of Convertible Preferred Stock One
StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStockOne
0
CY2018Q1 nwbo Stock Issued During Period Value Conversion Of Convertible Preferred Stock One
StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStockOne
994000
CY2019Q1 nwbo Adjustments To Additional Paid In Capitaldeemed Dividends Related To Conversion Of Preferred Convertible Stock Into Common Stock One
AdjustmentsToAdditionalPaidInCapitaldeemedDividendsRelatedToConversionOfPreferredConvertibleStockIntoCommonStockOne
0
CY2018Q1 nwbo Adjustments To Additional Paid In Capitaldeemed Dividends Related To Conversion Of Preferred Convertible Stock Into Common Stock One
AdjustmentsToAdditionalPaidInCapitaldeemedDividendsRelatedToConversionOfPreferredConvertibleStockIntoCommonStockOne
177000
CY2019Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0
CY2018Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1074000
CY2019Q1 nwbo Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived
2213000
CY2018Q1 nwbo Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived
1767000
CY2019Q1 nwbo Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
788000
CY2018Q1 nwbo Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
-215000
CY2019Q1 us-gaap Notes Payable
NotesPayable
135000
CY2018Q4 us-gaap Notes Payable
NotesPayable
135000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-56000
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
870000
CY2019Q1 nwbo Debt Conversion Converted Instrument Associate Warrants
DebtConversionConvertedInstrumentAssociateWarrants
0
CY2018Q1 nwbo Debt Conversion Converted Instrument Associate Warrants
DebtConversionConvertedInstrumentAssociateWarrants
2217000
CY2018 nwbo Class Of Warrant Or Right Oustanding Remaining Contractual Term
ClassOfWarrantOrRightOustandingRemainingContractualTerm
P1Y11M19D
CY2019Q1 nwbo Class Of Warrant Or Right Oustanding Remaining Contractual Term
ClassOfWarrantOrRightOustandingRemainingContractualTerm
P1Y8M19D
CY2019Q1 nwbo Shares Issued During Period Shares Upon Exercise Of Warrants
SharesIssuedDuringPeriodSharesUponExerciseOfWarrants
3000000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4864000
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
270000
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4749000
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2019Q1 nwbo Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
26000
CY2018Q1 nwbo Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
0
CY2019Q1 nwbo Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
129000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7766000
CY2018Q1 nwbo Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
0
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
155000
CY2019Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
95000
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
2000
CY2019Q1 us-gaap Lease Cost
LeaseCost
252000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
0
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4890000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
244000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
983000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
735000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
651000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
651000
CY2019Q1 nwbo Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
651000
CY2019Q1 nwbo Lessee Operating Lease Liability Payments Due After Year Six
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
9116000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13031000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8012000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5019000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4300000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
4300000
CY2019Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P20Y
CY2019Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4400000
CY2018Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
5400000
CY2019Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
400000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
43000
CY2019Q1 nwbo Prepayment Of Premium
PrepaymentOfPremium
27000
CY2019Q1 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
4802000
CY2019Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08
CY2019Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2020-11-29
CY2019Q1 nwbo Original Issue Discount Rate
OriginalIssueDiscountRate
0.10
CY2019Q1 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
4000000
CY2019Q1 nwbo Prepayment Premium Rate
PrepaymentPremiumRate
0.15
CY2019Q1 nwbo Debt Premium Rate
DebtPremiumRate
0.10
CY2019Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4400000
CY2018Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
3700000
CY2018Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.10
CY2018Q4 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
200000
CY2019Q1 us-gaap Revenues
Revenues
339000
CY2018Q1 us-gaap Revenues
Revenues
132000
CY2019Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
8105000
CY2018Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
8948000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8816000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13180000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12729000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-20946000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-21545000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20890000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22415000
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20946000
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-31601000
CY2019Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
688000

Files In Submission

Name View Source Status
0001144204-19-025347-index-headers.html Edgar Link pending
0001144204-19-025347-index.html Edgar Link pending
0001144204-19-025347.txt Edgar Link pending
0001144204-19-025347-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nwbo-20190331.xml Edgar Link completed
nwbo-20190331.xsd Edgar Link pending
nwbo-20190331_cal.xml Edgar Link unprocessable
nwbo-20190331_def.xml Edgar Link unprocessable
nwbo-20190331_lab.xml Edgar Link unprocessable
nwbo-20190331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv521011_10q.htm Edgar Link pending
tv521011_ex31-1.htm Edgar Link pending
tv521011_ex32-1.htm Edgar Link pending